RPS6KB1 and obesity disorder: These results confirm the potential of reducing the adipogenic commitment and adipocyte hypertrophy in adipocyte progenitors (Supplemental Figure 1C), thus inhibiting the onset of obesity by a compound targeting S6K1 in adipose tissue.